Roquefort Therapeutics plc

LSE:ROQ.L

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Chemicals & Advanced Materials

🔬 Clinical Trials

💊 Pharmaceuticals

💰 Venture Capital

Location

United Kingdom

Market Cap

USD 2.70 M

Share Price

USD 0.02

Avg Daily Volume

2,725,596

Change (1 day)

-7.45%

Change (1 year)

-71.73%

Change (YTD)

-66.15%

Roquefort Therapeutics plc Revenue Per Share for the year ending December 31, 2023: USD 0.00

Roquefort Therapeutics plc Revenue Per Share is USD 0.00 for the year ending December 31, 2023. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.

Roquefort Therapeutics plc Revenue Per Share for the year ending December 31, 2022 was USD 0.00, a -100.00% change year over year.
Roquefort Therapeutics plc Revenue Per Share for the year ending December 31, 2021 was USD 0.00.

Quarterly
Annual
TTM

From:

To:

Zoom:

1Y
3Y
5Y
10Y
15Y
20Y
Max

Key data

Date	Revenue Per Share	Free Cash Flow Per Share	Dividend Per Share	Debt to Equity Ratio

LSE: ROQ.L

Roquefort Therapeutics plc

CEO	Mr. Stephen Paul West B.Com, CA
IPO Date	March 22, 2021
Location	United Kingdom
Headquarters	Eccleston Yards
Employees	7
Sector	🏥 Health Care
Industries Biotechnology 🔬 Chemicals & Advanced Materials 🔬 Clinical Trials 💊 Pharmaceuticals 💰 Venture Capital

Description

Roquefort Therapeutics plc operates as a biotechnology research company. The company engages in the research and development of drugs targeting Midkine, a circulating growth factor protein and pro-inflammatory mediator for the treatment of cancer. Roquefort Therapeutics plc was incorporated in 2020 and is headquartered in London, the United Kingdom.

Similar companies

Samsung Biologics Co.,Ltd.

USD 727.08

-0.57%

Royalty Pharma plc

USD 35.87

1.70%

AbbVie Inc.

USD 182.31

-2.40%

Novo Nordisk A/S

USD 68.56

1.71%

Roche Holding AG

USD 347.50

0.20%

Abbott Laboratories

USD 134.38

0.53%

Novartis AG

USD 120.31

0.29%

AstraZeneca PLC

USD 140.24

0.73%

Merck & Co., Inc.

USD 79.10

0.34%

Thermo Fisher Scientific Inc.

USD 408.28

-0.93%

Boston Scientific Corporation

USD 106.53

1.86%

Amgen Inc.

USD 277.13

-0.71%

Pfizer Inc.

USD 24.19

-0.21%

Gilead Sciences, Inc.

USD 110.67

2.83%

Sanofi

USD 96.65

0.37%

Vertex Pharmaceuticals Incorporated

USD 441.30

-0.47%

Bristol-Myers Squibb Company

USD 46.35

-0.64%

Chugai Pharmaceutical Co., Ltd.

USD 51.91

-1.13%

GSK plc

USD 19.28

0.69%

CSL Limited

USD 153.01

-2.58%

Siemens Healthineers AG

USD 54.95

0.27%

MERCK Kommanditgesellschaft auf Aktien

USD 131.98

1.04%

Regeneron Pharmaceuticals, Inc.

USD 521.00

0.00%

Becton, Dickinson and Company

USD 170.86

0.52%

Jiangsu Hengrui Medicine Co., Ltd.

USD 7.24

-0.32%

Takeda Pharmaceutical Company Limited

USD 30.16

-0.03%

Alnylam Pharmaceuticals, Inc.

USD 322.83

1.44%

UCB SA

USD 199.41

0.97%

GE HealthCare Technologies Inc.

USD 74.38

-0.64%

Agilent Technologies, Inc.

USD 119.17

-0.21%

Bayer AG

USD 31.61

2.81%

Celltrion, Inc.

USD 116.73

-0.46%

WuXi AppTec Co., Ltd.

USD 9.68

-1.75%

BioNTech SE

USD 107.38

1.92%

Natera, Inc.

USD 167.96

-0.12%

Hansoh Pharmaceutical Group Company Limited

USD 3.71

-0.01%

Laboratory Corporation of America Holdings

USD 260.59

1.41%

Insmed Incorporated

USD 99.49

-2.21%

Biogen Inc.

USD 126.08

-0.66%

Astellas Pharma Inc.

USD 9.69

0.99%

bioMérieux S.A.

USD 139.42

-0.45%

Innovent Biologics, Inc.

USD 9.85

-1.60%

Summit Therapeutics Inc.

USD 20.60

-3.38%

Baxter International Inc.

USD 30.39

-0.36%

ALTEOGEN Inc.

USD 277.76

-1.44%

Shionogi & Co., Ltd.

USD 17.51

-0.68%

Illumina, Inc.

USD 94.79

0.67%

Incyte Corporation

USD 68.37

-3.45%

Torrent Pharmaceuticals Limited

USD 39.09

3.96%

StockViz Staff

June 28, 2025

Any question? Send us an email